1 Deadly Disease Getting Plenty of Attention (AZN, BMY, MNKD, PFE)

1 Deadly Disease Getting Plenty of Attention

Today, Brenton Flynn discusses a deadly disease that all of the Big Pharma heavies are looking to cash in on: diabetes. With undeniable secular trends like an aging and increasingly overweight population, some reports have gone as far as to project 50 million diabetic Americans on the horizon.

Brenton offers up some companies that are positioned to win big if they're able to put out successful drugs targeting this disease.

When it comes to do-or-die businesses, the biotech industry takes the cake. Arena Pharmaceuticals is one recent success story in the industry after gaining FDA approval for its innovative obesity drug. While the future looks bright for Arena, there are still plenty of obstacles ahead. In our brand-new premium research report on Arena Pharmaceuticals, we walk investors through the must-know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of updates for those who sign up. Click here now to learn more.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Brenton Flynn and The Motley Fool have no positions in the stocks mentioned above. Motley Fool newsletter services recommend MannKind. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

updated 5 hours ago Sponsored by:
	DOW	15,294.50	-12.67	-0.08%
	S&P 500	1,650.51	-4.84	-0.29%
	NASD	3,459.42	-3.88	-0.11%

MNKD	$6.85		+0.62	+9.95%
MannKind Corp		CAPS Rating:

PFE	$29.11		-0.19	-0.65%
Pfizer		CAPS Rating:

AZN	$3432.39		-53.11	+0.00%
AstraZeneca		CAPS Rating:

BMY	$47.00		+0.60	+1.29%
Bristol-Myers Squi…		CAPS Rating:

My Watchlist

3

1 Deadly Disease Getting Plenty of Attention

Comments from our Foolish Readers

Be the first one to comment on this article.

Compare Brokers

Report This Comment

Sending report...

Today's Market

Create My Watchlist

You don't seem to be following any stocks yet!

Related Tickers